<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01330121</url>
  </required_header>
  <id_info>
    <org_study_id>IRB #10-165</org_study_id>
    <nct_id>NCT01330121</nct_id>
  </id_info>
  <brief_title>Bridging the Gap by Transitional Care</brief_title>
  <official_title>Pharmacist Discharge Counseling: Bridging the Gap by Transitional Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>John H. Stroger Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>John H. Stroger Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate patient adherence with discharge diabetes medications
      up to 120 days following pharmacist counseling during hospital stay about diabetes self
      management
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a prospective, randomized, controlled Study. Patients randomized in a 1:1 ratio to
      pharmacist counseling or standard of therapy prior to discharge.

      Standard therapy: Nurses distribute a education pamphlet on diabetes.

      Pharmacist Counseling includes but is not limited to:

        -  Reviewing and explaining their medications (dosing, side effects, route)

        -  Reviewing symptoms and complications of hyper and hypoglycemia

        -  Defining glycemic &amp; non-glycemic goal levels

        -  Explaining the importance of compliance with medications &amp; appointments

        -  Educating on the basics of nutrition and physical activity
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence with discharge diabetes medications up to 120 days following pharmacist counseling during hospital stay about diabetes self management</measure>
    <time_frame>up to 120 days</time_frame>
    <description>The primary efficacy endpoint will be the difference in rate of adherence with medications Adherence will be assessed at 30, 60, 90, and 120 days following discharge An average of the total adherence rate 120 days following discharge will be calculated as the primary outcome measure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in HbA1c, blood pressure, and lipid panel 90 days following pharmacist counseling</measure>
    <time_frame>up to 90 days</time_frame>
    <description>To evaluate changes in glycosylated hemoglobin (HbA1c), blood pressure (BP), and lipid panel 90 days following pharmacist counseling
To demonstrate an improvement in health literacy following pharmacist counseling on diabetes
To evaluate patient compliance with follow up appointments up to 90 days following pharmacist counseling</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Diabetes Mellitus Type 2</condition>
  <arm_group>
    <arm_group_label>Pharmacist Counseling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pharmacist Counseling includes but is not limited to:
Reviewing and explaining their medications (dosing, side effects, route) Reviewing symptoms and complications of hyper and hypoglycemia Defining glycemic &amp; non-glycemic goal levels Explaining the importance of compliance with medications &amp; appointments Educating on the basics of nutrition and physical activity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard therapy: Nurses distribute a education pamphlet on diabetes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pharmacist Counseling</intervention_name>
    <description>Pharmacist Counseling includes but is not limited to:
Reviewing and explaining their medications (dosing, side effects, route) Reviewing symptoms and complications of hyper and hypoglycemia Defining glycemic &amp; non-glycemic goal levels Explaining the importance of compliance with medications &amp; appointments Educating on the basics of nutrition and physical activity</description>
    <arm_group_label>Pharmacist Counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females

          -  18 to 85 years of age

          -  Historical diagnosis of type 2 diabetes mellitus greater than one year

          -  HbA1c concentration â‰¥ 8%

          -  Discharged from general medicine unit of John H. Stroger Jr, Hospital of Cook County

          -  Patient with provider and prescriptions filled within CCHS

        Exclusion Criteria:

          -  Type 1 diabetes mellitus

          -  Pregnancy

          -  Major illness or debility, that prohibits the subject from participating in the study

          -  History of any hemoglobinopathy that may affect determination of HbA1c

          -  Non-English speaking patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leon Fogelfeld, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>John H. Stroger Hospital of Cook County, Division of Endocrinology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>John H. Stroger Jr. Hospital of Cook County</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 5, 2011</study_first_submitted>
  <study_first_submitted_qc>April 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2011</study_first_posted>
  <last_update_submitted>April 5, 2011</last_update_submitted>
  <last_update_submitted_qc>April 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Leon Fogelfeld, M.D.</name_title>
    <organization>John H. Stroger Hospital of Cook County, Division of Endocrinology</organization>
  </responsible_party>
  <keyword>Adherence with discharge diabetes medications</keyword>
  <keyword>Diabeted mellitus type 2 greater than one year</keyword>
  <keyword>Patient with provider and prescriptions filled within CCHS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

